Anil Shah

3 weeks ago | modernaesthetics.com | Anil Shah |Alyssa Adams |Jason Mazda

Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA approval in November 2024, offer an expanded size range—930 cc to 1445 cc—designed to meet the reconstructive needs of women with larger body frames or significant tissue removal.

1 month ago | modernaesthetics.com | Anil Shah |Alyssa Adams |Jason Mazda

In response to rising rates of revision surgery and dissatisfaction with overly augmented results, an international coalition of leading plastic surgeons has introduced new framework for achieving more natural outcomes in breast augmentation. The Global Consensus on Natural Breast Beauty, launched April 11 at Palazzo Turati in Milan, aims to shift the focus in aesthetic breast surgery from volume-driven trends to patient-centered, anatomy-based planning.

2 months ago | modernaesthetics.com | Anil Shah |Alyssa Adams |Jason Mazda

The research firm Clarivate projected the global aesthetics market to reach a value of €22.9 billion by 2028, growing at a compound annual growth rate (CAGR) of nearly 8%. This growth, Clarivate said, is driven by trends such as the shift toward natural-looking treatments, the rise of combination treatments, and the increasing impact of social media on cosmetic procedure awareness.